Edwards Lifesciences Shares Fall After Downgrade From Wolfe Research

MT Newswires Live
16 Jan

Edwards Lifesciences (EW) shares were down nearly 1% in recent trading Thursday after Wolfe Research downgraded the company's stock to underperform from peer perform, with a price target of $60.

Trading volume stood at 4 million shares against a daily average of roughly 5 million.

Price: 69.79, Change: -0.49, Percent Change: -0.70

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."